SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-019640
Filing Date
2019-12-23
Accepted
2019-12-23 17:06:43
Documents
12
Period of Report
2019-12-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 36270
2 ex3-1.htm EX-3.1 10045
3 ex3-1_001.jpg GRAPHIC 121462
4 ex3-1_002.jpg GRAPHIC 195272
5 ex3-1_003.jpg GRAPHIC 169377
6 ex3-1_004.jpg GRAPHIC 168823
7 ex3-1_005.jpg GRAPHIC 201467
8 ex3-1_006.jpg GRAPHIC 187572
9 ex3-1_007.jpg GRAPHIC 185666
10 ex3-1_008.jpg GRAPHIC 194885
11 ex3-1_009.jpg GRAPHIC 125525
12 ex3-1_010.jpg GRAPHIC 153852
  Complete submission text file 0001493152-19-019640.txt   2395080
Mailing Address 75 INTERNATIONAL BLVD., SUITE 300 TORONTO A6 M9W 6L9
Business Address 75 INTERNATIONAL BLVD., SUITE 300 TORONTO A6 M9W 6L9 (416) 214-3678
BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)

IRS No.: 472548273 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-56074 | Film No.: 191306956
SIC: 3841 Surgical & Medical Instruments & Apparatus